###begin article-title 0
The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease
###end article-title 0
###begin p 1
###xml 31 57 31 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">littman@saturn.med.nyu.edu</email>
CORRESPONDENCE Dan R. Littman: littman@saturn.med.nyu.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 408 414 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nature</italic>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 692 698 692 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer</italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 765 766 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
MicroRNAs (miRNAs) are implicated in the differentiation and function of many cell types. We provide genetic and in vivo evidence that the two RNaseIII enzymes, Drosha and Dicer, do indeed function in the same pathway. These have previously been shown to mediate the stepwise maturation of miRNAs (Lee, Y., C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark, S. Kim, and V.N. Kim. 2003. Nature. 425:415-419), and genetic ablation of either within the T cell compartment, or specifically within Foxp3+ regulatory T (T reg) cells, results in identical phenotypes. We found that miRNA biogenesis is indispensable for the function of T reg cells. Specific deletion of either Drosha or Dicer phenocopies mice lacking a functional Foxp3 gene or Foxp3+ cells, whereas deletion throughout the T cell compartment also results in spontaneous inflammatory disease, but later in life. Thus, miRNA-dependent regulation is critical for preventing spontaneous inflammation and autoimmunity.
###end p 3
###begin p 4
Abbreviations used: DP, double positive; dsRNA, double-stranded RNA; H&E, hematoxylin and eosin; miRNA, microRNA; pri-miRNA, primary miRNA; RA, retinoic acid; rRNA, ribosomal RNA; siRNA, small inhibitory RNA.
###end p 4
###begin p 5
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 823 824 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
Appropriate regulation of immune homeostasis is critical for ensuring adequate immunity toward harmful pathogens without uncontrolled inflammation that could lead to tissue damage. T reg cells have a critical role in homeostasis by suppressing the activation of autoreactive T cells. Either mutations in the gene encoding Foxp3, a transcription factor required for T reg cell differentiation, or ablation of T reg cells results in devastating autoimmune lymphoproliferative disease (1-4). Chronic inflammation and autoimmunity can also result from defective activation of apoptosis that is normally required for the contraction of effector T cells after an immune response (5-7). Dysregulated cytokine signaling can also lead to spontaneous T cell activation and inflammatory disease, independently of antigen stimulation (8-10).
###end p 5
###begin p 6
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 405 407 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
A hallmark of T reg cells is the expression of the forkhead transcription factor Foxp3. "Natural" Foxp3-expressing T cells arise in the thymus from a subset of thymocytes selected on class II MHC (11). Expression of Foxp3 is also induced in naive CD4+ T cells in response to antigen stimulation in the presence of TGF-beta. These inducible T reg cells have also been shown to have suppressive activities (12).
###end p 6
###begin p 7
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
The decision of precursor cells to differentiate into phenotypically and functionally distinct lineages, such as occurs when immature CD4+8+ double-positive (DP) thymocytes differentiate into cytotoxic CD8+, helper CD4+, or regulatory Foxp3+ T cells, is ultimately governed by the regulation of gene expression in response to intrinsic or extrinsic signals. Gene expression is regulated at multiple levels, from chromatin organization to transcription to posttranscriptional controls. It is now clear that not only proteins but also small regulatory RNAs play critical roles at each of these levels of regulation.
###end p 7
###begin p 8
###xml 244 246 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 607 609 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 611 613 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 856 858 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
MicroRNAs (miRNAs) are short (approximately22 nt) noncoding RNAs, expressed from endogenous genes, that act on target protein-encoding mRNAs through the RNA-induced silencing complex, targeting them for translational repression or degradation (13). The biogenesis of miRNAs involves two processing steps that have been largely defined in cell-based and biochemical studies. Primary miRNA (pri-miRNA) transcripts are first cleaved by the nuclear "microprocessor" complex containing the RNaseIII enzyme Drosha and its double-stranded RNA (dsRNA) binding partner DGCR8/Pasha, leaving short hairpin pre-miRNAs (14, 15). These pre-miRNAs are then exported to the cytoplasm, where they are further processed by another RNaseIII enzyme, Dicer, and its dsRNA binding partner, TRBP, to liberate the mature miRNAs for loading into the RNA-induced silencing complex (16).
###end p 8
###begin p 9
###xml 117 139 117 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 117 139 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
Genetic studies have clearly demonstrated a critical requirement for Dicer in vivo. Dicer deficiency in the nematode Caenorhabditis elegans causes sterility (17), whereas deficiency in mice results in early embryonic lethality (18). Dicer has also been shown to have critical functions in the differentiation of specific tissues, such as skeletal muscle (19), pancreatic islets (20), and B lymphocytes (21). The function of Dicer, however, is not limited to miRNA biogenesis. Dicer is also required for the generation of small inhibitory RNAs (siRNAs) derived from endogenous dsRNA transcripts or exogenous sources of dsRNAs, including viruses and experimental siRNAs. siRNAs derived from endogenous dsRNAs may also play important roles in gene regulation. siRNAs generated from pseudogene-derived dsRNAs may regulate complementary protein-coding transcripts, analogous to miRNAs, whereas siRNAs from retrotranspon-derived dsRNAs appear to be important for genome stability (22, 23). Thus, although the loss of miRNA-dependent regulation is implicated in the phenotypes caused by Dicer deficiency, it is not known whether they are a consequence solely of the loss of miRNAs or if the loss of other Dicer functions also contributes.
###end p 9
###begin p 10
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LoxP</italic>
###xml 385 391 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LoxP</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer</italic>
###xml 974 975 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
Unlike Dicer, Drosha is thought to be required for the biogenesis of miRNAs but not in the generation of other siRNAs. However, an early report suggested that this RNaseIII enzyme is required for processing of the preribosomal RNA (pre-rRNA) (24). To investigate specifically the function of miRNA-dependent regulation, we generated mice with a targeted conditional LoxP allele of the Drosha gene and compared these with mice with a conditional LoxP allele of Dicer. By specifically inactivating these genes in T lymphocytes, we found that Drosha is indeed required for the biogenesis of miRNAs but not for the expression of rRNA subunits. Both Drosha- and Dicer-dependent pathways were critical for the induction of Foxp3 and function of the T reg lineage. Consequently, the loss of Drosha throughout the T cell compartment resulted in spontaneous T cell activation, inflammatory disease, and premature lethality. The absence of either Drosha or Dicer specifically in Foxp3+ T reg cells was even more devastating, resulting in early onset lymphoproliferative disease, analogous to Foxp3 or T reg deficiency. Thus, we provide the first genetic and in vivo evidence that Drosha and Dicer function in the same pathway, and that this pathway, in the biogenesis of miRNAs, is critical for immune regulation and preventing lethal inflammatory disease.
###end p 10
###begin title 11
RESULTS
###end title 11
###begin title 12
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Specific miRNA deficiency in mice with Drosha deficiency in the T cell compartment
###end title 12
###begin p 13
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rnasen</italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Etohi2</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 991 997 991 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 474 479 <span type="species:ncbi:10090">mouse</span>
###xml 1180 1184 <span type="species:ncbi:10090">Mice</span>
The mouse Drosha gene (also known as Rnasen or Etohi2) consists of 35 exons spanning 110 kb on chromosome 15 (Fig. S1 A, available at ). The full-length Drosha transcript was predicted to be 4.5 kb and to encode a 1,373-residue polypeptide (Fig. S1 B). However, an initial survey of expressed sequence tags that mapped to the Drosha locus suggested that multiple splice isoforms might exist. By using sequential primer pairs to amplify cDNA reverse transcribed from various mouse tissues, two alternately spliced isoforms were identified in addition to the full-length transcript. These were products of splicing between exons 2 and 7 and exons 4 and 7 of the primary transcript (Fig. S1, C and D). Although the full-length transcript was always the predominant species, both alternately spliced isoforms were predicted to be in frame. We therefore used a targeting strategy that would disrupt all three potential Drosha transcripts. By gene targeting in embryonic stem cells, a conditional Drosha allele (F) was generated by flanking exon 9 with LoxP sites (Fig. S2 A), which if deleted was predicted to cause a frame shift and the appearance of multiple stop codons in exon 11. Mice were generated from these cells, and subsequent recombination of the conditional allele in the germ line yielded the null allele (Delta; Fig. S2 B).
###end p 13
###begin p 14
###xml 19 26 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 13 26 13 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup></italic>
###xml 202 204 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 237 244 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 231 244 227 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup></italic>
###xml 627 633 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 641 649 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 887 894 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 881 902 873 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 992 1000 980 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1343 1351 1331 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 115 130 <span type="species:ncbi:10090">transgenic mice</span>
###xml 207 211 <span type="species:ncbi:10090">Mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
Heterozygous DroshaF/Delta mice, which harbor only one functional Drosha allele, were viable. These were bred with transgenic mice expressing cre under regulation of the CD4 promoter/enhancer/silencer (25). Mice were maintained as DroshaF/Delta heterozygotes to ensure efficient deletion whenever cre was expressed. CD4-cre efficiently recombined the conditional allele at the DNA and transcript levels at the DP thymocyte stage. Deletion of the conditional allele was similarly observed in mature peripheral T cells, indicating that there was no preferential selection of cells that had failed to undergo recombination at the Drosha locus (Fig. 1 A and Fig. S2 C). Expression of the full-length Drosha protein, which was the only isoform detected in wild-type lymphocytes by Western blotting, was markedly reduced in DP thymocytes and was completely absent from mature T cells in DroshaF/Delta CD4-cre mice. This resulted in the loss of pre-miRNAs and mature miRNAs specifically in T cells (Fig. 1 C). However, the expression of some mature miRNAs, such as miR-29a, was only partially down-regulated in the absence of Drosha, suggesting that different miRNA species may have different stabilities. Consistent with a function for the processing of pri-miRNA, an accumulation of pri-miR-150 transcript was detected in Drosha-deficient T cells (Fig. 1 D).
###end p 14
###begin p 15
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Drosha deficiency abrogates miRNA but not rRNA processing.</bold>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 325 327 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 338 339 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 348 349 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 350 351 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 367 369 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 373 375 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 376 377 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 378 379 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 395 397 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 401 403 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 404 405 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 406 407 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 479 480 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 497 498 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 518 525 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 512 533 500 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 552 555 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 546 563 530 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
Drosha deficiency abrogates miRNA but not rRNA processing. (A) CD4-cre efficiently deletes exon 9 from the conditional Drosha transcript from the DP thymocyte stage onwards. cDNA from the indicated populations was analyzed for expression of the Drosha exons 5/6 or exon 9/10 junction by quantitative RT-PCR. DN4, CD90+TCRbetaloCD4/8/44/25-; DP, CD4+8+; CD4SP, TCRbetahiCD24lo4+8-; CD8SP, TCRbetahiCD24lo4-8+. (B) Drosha protein expression in DP thymocytes, and peripheral TCRbeta+ T cells and B220+ B cells from DroshaF/Delta CD4-cre and control DroshaF/+ CD4-cre mice. Molecular weights are shown. (C) Total RNA from DP thymocytes and peripheral T and B cells was resolved on a polyacrylamide gel and Northern blotted for expression of mature miRNAs. Also shown is the ethidium bromide gel for expression of small rRNA and transfer RNA species. (D) Total RNA was resolved on an agarose-formaldehyde gel and Northern blotted for expression of pri-miR-150. Also shown is the ethidium bromide gel for expression of the large rRNA subunits.
###end p 15
###begin p 16
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">28S</italic>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S</italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5.8S</italic>
###xml 210 212 210 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5S</italic>
###xml 286 301 286 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
It was previously suggested that Drosha might be required for processing of the pre-rRNA transcript into the smaller ribosomal subunits (24). However, we found no difference in the level of 28S, 18S, 5.8S, and 5S rRNAs expressed in Drosha-deficient T cells compared with control cells (Fig. 1, C and D). Therefore, Drosha appears to be specific for the processing of pri-miRNA transcripts.
###end p 16
###begin title 17
Drosha deficiency at the DP thymocyte stage results in T lymphopenia
###end title 17
###begin p 18
###xml 68 75 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 62 83 62 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 105 113 101 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 224 226 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 247 248 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 383 398 368 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B and D</xref>
###xml 475 476 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 527 535 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
A reduction in the number of total thymocytes was observed in DroshaF/Delta CD4-cre mice at 6 wk of age (Fig. 2 A). An analysis of cell surface markers did not reveal a loss of any particular thymocyte subpopulation. TCRbetahi versus TCRgammadelta+ populations appeared similar to littermate controls, as did expression of CD4 and CD8 at various stages of thymocyte differentiation (Fig. 2, B and D). One subtle difference observed was a reduction in the frequency of TCRbeta+ thymocytes that had down-regulated CD24 and CD69 (Fig. 2 C), suggesting a partial perturbation in the ability of Drosha-deficient thymocytes to mature after selection.
###end p 18
###begin p 19
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Drosha deficiency at the DP thymocyte stage partially perturbs thymocyte output.</bold>
###xml 133 140 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 127 148 127 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 159 162 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 153 170 149 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 291 293 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 373 375 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 379 381 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 384 385 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 406 408 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 412 414 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 417 418 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 507 508 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 627 628 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 629 630 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 664 665 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 739 740 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
Drosha deficiency at the DP thymocyte stage partially perturbs thymocyte output. (A) Total thymocyte and splenocyte numbers in DroshaF/Delta CD4-cre and DroshaF/+ CD4-cre (control) mice. (B) TCRbeta versus TCRgammadelta expression on total thymocytes. (C) CD24 and CD69 expression on TCRbetahi gated thymocytes. (D) CD4 versus CD8 expression on total, postselected (TCRbetahiCD24hi/69+) and mature (TCRbetahiCD24lo/69-) thymocytes. (E and F) FACS analysis of populations in total splenocytes (E) and TCRbeta+ splenocytes (F). Also shown is the effect of Dicer deficiency. Percentages of cells are shown in B-F. (G) Absolute CD4+8+ DP, mature thymocyte, and TCRbeta+ splenocyte numbers. (H) CD4/CD8 ratio in the mature thymocyte and TCRbeta+ splenocyte compartments.
###end p 19
###begin p 20
###xml 155 163 155 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 G</xref>
###xml 255 270 255 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, E and G</xref>
###xml 363 370 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 357 378 357 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 473 474 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 501 516 497 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, F and H</xref>
###xml 608 609 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
Although thymocyte subpopulation profiles appeared normal, absolute numbers of DP and mature thymocytes were significantly reduced with Drosha deficiency (Fig. 2 G). This translated into a reduction in the number of mature T cells found in the periphery (Fig. 2, E and G). Furthermore, although the ratio of CD4 to CD8 mature thymocytes was similar between DroshaF/Delta CD4-cre mice and littermate controls, there was a significant reduction in the frequency of mature CD8+ T cells in the periphery (Fig. 2, F and H). Thus, T cell-specific Drosha deficiency results in T lymphopenia, particularly in the CD8+ compartment, and suggests a requirement for miRNAs in the homeostasis of mature T cells.
###end p 20
###begin title 21
T cell-specific deficiency results in spontaneous inflammatory disease and premature mortality
###end title 21
###begin p 22
###xml 108 115 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 102 123 102 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 274 281 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 268 289 264 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 459 466 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 453 474 445 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 482 490 470 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
To investigate the consequence of losing Drosha-dependent regulatory pathways in T cells, a cohort of DroshaF/Delta CD4-cre mice and various littermate controls was monitored in a long-term survival study. From around 4 mo of age, cachexia was observed in many of the DroshaF/Delta CD4-cre mice. These became moribund soon thereafter, at which point they were killed with littermate controls for analysis. By 6 mo, there was a 50% mortality rate in the DroshaF/Delta CD4-cre group (Fig. 3 A).
###end p 22
###begin p 23
###xml 0 102 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T cell&#8211;specific Drosha deficiency results in spontaneous inflammatory disease and premature mortality.</bold>
###xml 143 150 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 137 158 137 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 183 186 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 177 186 173 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/F</sup></italic>
###xml 194 199 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 188 199 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>&#916;</sup></italic>
###xml 199 201 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/+</sup>
###xml 213 216 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 207 224 199 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 257 258 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 304 311 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 298 319 290 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 362 363 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 375 376 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 443 444 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 475 476 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
T cell-specific Drosha deficiency results in spontaneous inflammatory disease and premature mortality. (A) Kaplan-Meyer survival plot of DroshaF/Delta CD4-cre and control mice (DroshaF/F, DroshaDelta/+ , or DroshaF/+ CD4-cre). (B) Aberrant activation of CD4+ T cells in lymphoid organs of moribund DroshaF/Delta CD4-cre mice. (C and D) Cytokine expression by CD4+ (C) and CD8+ (D) T cells. (E) Frequent IFN-gamma and IL-17A coexpression by CD4+ T cells. (F) Granulocyte (Gr-1+) and gammadeltaT cells populations in lymphoid organs. Percentages of cells are shown in B-F. (G) H&E-stained sections of the lung (i and iii) and liver (ii, iv, and v). Bars, 100 mum.
###end p 23
###begin p 24
###xml 108 115 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 102 123 102 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 189 191 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 193 195 189 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 200 201 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 254 262 250 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 356 364 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 609 611 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 613 615 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 662 669 654 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 656 677 648 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 764 772 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 925 926 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 950 951 930 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 995 1002 975 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 989 1010 969 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1264 1272 1240 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 1376 1377 1344 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1426 1441 1394 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, B and D</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1420 1424 <span type="species:ncbi:10090">mice</span>
A reduction in muscle mass and a complete loss of visceral adipose tissue was evident in all moribund DroshaF/Delta CD4-cre mice. A substantial increase in the frequency of activated (CD62Llo44hi) CD4+ T cells was observed in the spleen and lymph nodes (Fig. 3 B). Furthermore, very high frequencies of IFN-gamma- and IL-17A-secreting cells were observed (Fig. 3 C). IL-17A expression was particularly prominent, as significant levels of IL-17A are normally only observed at mucosal surfaces, such as the small intestine, and in some autoimmune diseases, such as in experimental autoimmune encephalomyelitis (26, 27). Another prominent feature in moribund DroshaF/Delta CD4-cre mice was the presence of a high frequency of IFN-gamma/IL-17A double-secreting cells (Fig. 3 E), which has also been observed in autoimmune models such as experimental autoimmune encephalomyelitis. A marginal increase in the frequency of IFN-gamma+-or IL-17A-secreting CD4+ T cells could already be detected in DroshaF/Delta CD4-cre mice at 3 mo of age (Fig. S3, available at ), suggesting a gradual accumulation of inflammatory cells in aging mice. Consistent with aberrant IL-17A expression, there was a significant increase in the frequency of granulocytes in these lymphoid organs (Fig. 3 F). An increase in gammadeltaT cells was also observed. Aberrant activation and cytokine secretion by CD8+ T cells was usually not observed in these mice (Fig. 3, B and D).
###end p 24
###begin p 25
###xml 77 85 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 402 413 402 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G, v</xref>
###xml 524 531 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 518 539 518 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
The liver and lung appeared to be the major organs affected by inflammation (Fig. 3 G; and Table S1, available at ). Infiltrating cells also accumulated in the lung, primarily around blood vessels, resulting in epithelial thickening of the surrounding tissue. Infiltrating cells accumulated around most vessels in the liver, with additional foci of inflammatory cells evident throughout the sinusoids (Fig. 3 G, v). In addition, small foci of inflammatory cells were more prevalent in the small intestine and colon of DroshaF/Delta CD4-cre mice compared with littermate controls.
###end p 25
###begin p 26
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 135 142 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 129 150 129 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
Despite aberrant CD4+ T cell activation, inflammatory cytokine secretion, and tissue inflammation, the spleen and lymph nodes of DroshaF/Delta CD4-cre mice were no larger than those in littermate controls (Fig. S4, A and B, available at ). In fact, the reduced thymic output and T lymphopenia remained a feature of these older mice (Fig. S4, C-E). Thus, T cell-specific Drosha deficiency results in lethal inflammatory disease associated with lymphopenia.
###end p 26
###begin title 27
Drosha-dependent pathways are required for the induced Foxp3 expression and suppressive activity of T reg cells
###end title 27
###begin p 28
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 287 294 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 281 302 281 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 312 315 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 307 323 303 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> CD4-cre</italic>
###xml 352 360 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 492 493 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 507 515 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 641 642 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 646 648 642 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
It was previously suggested that Foxp3 contributes to the miRNA signature in T reg cells and that miRNA pathways contribute to the regulation of Foxp3 expression (28). Indeed, a reduction in the frequency of Foxp3+ thymocytes and mature peripheral T reg cells was observed in both DroshaF/Delta CD4-cre and DicerF/F CD4-cre conditional-deficient mice (Fig. 4 A). This reduction was not simply concurrent with the general T lymphopenia, because it was still evident when examining only the CD4+ compartment (Fig. 4 B). With both Drosha and Dicer deficiency, the reduction in the T reg cell population was largely caused by a loss of the Foxp3+CD25lo cells.
###end p 28
###begin p 29
###xml 0 122 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Drosha- and Dicer-dependent pathways are required for efficient induction of Foxp3 expression and function of T reg cells.</bold>
###xml 142 143 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 148 149 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 207 214 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 201 222 198 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 232 235 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 227 243 220 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> CD4-cre</italic>
###xml 448 450 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 452 454 445 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 456 457 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 461 462 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 482 489 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 476 497 469 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 504 507 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 499 515 488 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> CD4-cre</italic>
###xml 535 538 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 529 546 518 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 884 885 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 897 903 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd45.1</italic>
###xml 958 959 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 961 962 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 980 987 963 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 974 995 957 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1005 1008 984 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 999 1016 978 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 1018 1024 997 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd45.2</italic>
###xml 1155 1156 1134 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 1026 1030 <span type="species:ncbi:10090">mice</span>
Drosha- and Dicer-dependent pathways are required for efficient induction of Foxp3 expression and function of T reg cells. (A) Reduced TCRbeta+Foxp3+ T reg cell populations in the thymus and spleen of DroshaF/Delta CD4-cre and DicerF/F CD4-cre mice. (B) Foxp3 expression in peripheral T reg cell populations in the absence of Drosha or Dicer. (C and D) Drosha and Dicer are required for efficient differentiation of induced T reg cells. Naive CD62Lhi44lo25- CD4+ T cells from DroshaF/Delta CD4-cre, DicerF/F CD4-cre, and control DroshaF/+ CD4-cre mice were activated in vitro with anti-CD3/28 antibodies plus 10 U/ml IL-2, and TGF-beta (C) or TGF-beta plus 10 nM RA (D) for 3 d. The cells were restimulated with PMA/ionomycin plus GolgiStop for 3 h, and Foxp3 and IL-17A expression was analyzed by intracellular FACS. Percentages of cells are shown in A-D. (E) FACS-purified naive CD4+ cells from Cd45.1 mice were loaded with CFSE and mixed with purified CD4+25+ cells from DroshaF/Delta CD4-cre or DroshaF/+ CD4-cre (Cd45.2) mice at the indicated ratios. These were then incubated with inactivated splenocytes and anti-CD3 antibody. After 4 d, the CD45.1+ cells were analyzed for CFSE dilution.
###end p 29
###begin p 30
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 178 180 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 182 184 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 295 296 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 330 337 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 324 345 321 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 355 358 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 350 366 343 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> CD4-cre</italic>
###xml 429 437 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 474 482 461 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 834 835 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 855 862 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 849 870 833 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1141 1142 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1176 1183 1156 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1190 1197 1166 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CreER/+</sup>
###xml 1170 1197 1150 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Rosa26<sup>CreER/+</sup></italic>
###xml 1399 1405 1369 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
Foxp3 expression can also be induced in naive CD4+ T cells upon antigen stimulation in the presence of TGF-beta, and this expression is enhanced and stabilized by retinoic acid (29, 30). To examine if Drosha- and Dicer-dependent pathways may also be required for inducible T reg cells, naive CD4+ T cells were purified from DroshaF/Delta CD4-cre and DicerF/F CD4-cre mice and were activated in vitro in the presence of TGF-beta (Fig. 4 C) or TGF-beta and retinoic acid (RA; Fig. 4 D). Induction of Foxp3 was markedly blunted in both Drosha- and Dicer-deficient cells, even in the presence of RA. The magnitude of Foxp3 induction was similar between Drosha- and Dicer-deficient cells. The defect in Drosha- and Dicer-deficient cells was especially noticeable at lower concentrations of TGF-beta. This defect in the ability of naive CD4+ T cells from DroshaF/Delta CD4-cre mice to up-regulate Foxp3 expression could be caused by generation of abnormal T cells that had been aberrantly selected in the absence of Drosha. To examine the requirement of Drosha-dependent pathways specifically during inducible T reg cell differentiation, naive CD4+ T cells were purified from DroshaF/Delta Rosa26CreER/+ mice, in which Cre only deletes upon the addition of tamoxifen (Fig. S5 A, available at ). Foxp3 induction by TGF-beta (Fig. S5 B) or TGF-beta and RA (Fig. S5 C) was still blunted when the conditional Drosha allele was deleted in vitro by tamoxifen addition, indicating that the observed defect was not caused by abnormal thymic selection.
###end p 30
###begin p 31
###xml 79 86 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 73 94 73 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 106 107 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 111 113 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 187 188 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 191 192 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 226 233 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 220 241 216 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 324 325 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 328 329 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 406 414 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 421 422 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 426 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 446 453 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 440 461 432 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 517 518 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 521 522 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 543 544 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 549 550 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 639 640 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 643 644 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 672 675 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 666 683 654 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 777 784 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 771 792 759 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1033 1040 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1027 1048 1011 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
Although the induction of Foxp3 expression was dramatically perturbed in DroshaF/Delta CD4-cre mice, Foxp3+CD25hi cells were still present. To examine if these cells were functional, CD25+CD4+ T cells were purified from DroshaF/Delta CD4-cre and control mice, and their ability to suppress the in vitro proliferation of CD25-CD4+ T cells in response to APCs and anti-CD3 antibody stimulation was examined (Fig. 4 E). CD25+CD4+ T cells from DroshaF/Delta CD4-cre mice could partially suppress the proliferation of CD25-CD4+ T cells at high CD25+/CD25- ratios. However, this activity was substantially reduced in comparison with that of CD25+CD4+ T cells from control DroshaF/+ CD4-cre mice. Thus, not only is there a reduction in T reg cell numbers and Foxp3 induction in DroshaF/Delta CD4-cre mice, but the remaining T reg cells have reduced suppressive activity, at least in vitro. This suggests that a defect in the T reg cell compartment may be the cause of or a major contributor to the spontaneous inflammatory disease in DroshaF/Delta CD4-cre mice.
###end p 31
###begin title 32
Drosha deficiency does not prevent the differentiation of Th1 or Th2 phenotype cells
###end title 32
###begin p 33
###xml 262 269 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 256 277 256 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 482 483 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 517 524 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 511 532 507 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 589 597 581 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 607 615 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 666 667 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 814 815 802 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 984 991 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 978 999 962 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1023 1024 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1044 1051 1024 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1058 1065 1034 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CreER/+</sup>
###xml 1038 1065 1018 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Rosa26<sup>CreER/+</sup></italic>
###xml 1121 1127 1093 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 1216 1217 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1317 1324 1285 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1311 1332 1279 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1346 1347 1310 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
It is possible that Drosha-dependent pathways may be specifically required for the differentiation and function of T reg cells. It is also possible that the differentiation of all T cell subsets may be affected by Drosha deficiency. The finding that older DroshaF/Delta CD4-cre mice display very high frequencies of proinflammatory cytokine-secreting cells suggests that the differentiation of other Th cell subsets may not be dependent on Drosha. To examine this further, naive CD4+ T cells were purified from DroshaF/Delta CD4-cre and control mice and were activated in vitro under Th1 (Fig. 5 A) or Th2 (Fig. 5 B) polarizing conditions. Drosha-deficient naive CD4+ T cells were still capable of differentiating into either IFN-gamma-secreting Th1 cells or IL-4-secreting Th2 cells. In fact, Drosha-deficient CD4+ T cells consistently expressed more IFN-gamma than controls under Th1 polarizing conditions. Again, this was not caused by defective thymocyte differentiation in DroshaF/Delta CD4-cre mice, because naive CD4+ T cells from DroshaF/Delta Rosa26CreER/+ mice also released more IFN-gamma when the conditional Drosha allele was deleted in vitro upon the addition of tamoxifen (Fig. S6, available at ). CD8+ T cell activation and IFN-gamma secretion did not appear to contribute to the disease in old DroshaF/Delta CD4-cre mice, and CD8+ T cells from these mice were capable of secreting IFN-gamma after activation in vitro (Fig. S7).
###end p 33
###begin p 34
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Drosha deficiency does not prevent polarization of naive CD4<sup>+</sup> T cells into Th1 or Th2 cells.</bold>
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 108 110 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 138 145 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 132 153 132 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 172 175 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 166 183 162 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> CD4-cre</italic>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
Drosha deficiency does not prevent polarization of naive CD4+ T cells into Th1 or Th2 cells. Naive CD62Lhi44lo25- CD4+ T cells from DroshaF/Delta CD4-cre and control DroshaF/+ CD4-cre mice were activated in vitro with anti-CD3/28 antibodies and 10 U/ml IL-2, plus (A) IL-12 and 1 mug/ml anti-IL-4 antibody or (B) IL-4 and 1 mug/ml anti-IFN-gamma antibody for 4 d. The anti-CD3/28 antibodies were removed from the culture for the last 24 h, after which the cells were restimulated with PMA/ionomycin for 3 h in the presence of GolgiStop and analyzed for intracellular IFN-gamma and IL-4 expression by FACS. Percentages of cells are shown.
###end p 34
###begin p 35
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 291 298 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 285 306 285 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
Thus, it appears that the defective T reg cell differentiation and function, together with the normal or enhanced differentiation of conventional CD4+ T cells into proinflammatory subsets, may be the mechanism underlying the spontaneous inflammatory disease and premature mortality in DroshaF/Delta CD4-cre mice.
###end p 35
###begin title 36
Drosha- and Dicer-dependent pathways are indispensable within the T reg cell compartment
###end title 36
###begin p 37
###xml 143 150 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 137 158 137 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 208 214 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 294 299 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 349 351 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 492 502 488 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 487 502 483 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 515 522 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 528 538 520 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 509 538 505 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 548 551 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 557 567 549 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 543 567 535 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 631 639 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 653 660 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 666 676 654 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 647 676 639 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 755 770 743 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B and C</xref>
###xml 908 909 896 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 919 927 907 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 967 969 955 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 971 973 959 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 977 978 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 986 987 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1043 1051 1031 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 E</xref>
###xml 1091 1092 1075 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1100 1101 1084 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1142 1143 1126 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1186 1201 1170 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, F and G</xref>
###xml 1295 1302 1279 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1308 1318 1288 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 1289 1318 1273 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 1325 1333 1305 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 J</xref>
###xml 1527 1532 1507 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 1560 1561 1540 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 1563 1564 1543 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 1613 1616 1593 1596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 1622 1632 1602 1612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 1608 1632 1588 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">Mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 1180 1184 <span type="species:ncbi:10090">mice</span>
###xml 1319 1323 <span type="species:ncbi:10090">mice</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
###xml 1633 1637 <span type="species:ncbi:10090">mice</span>
To determine if defective T reg cells enhanced Th1 cell differentiation, or if both are required for spontaneous inflammatory disease in DroshaF/Delta CD4-cre mice, we examined the effect of inactivating the Drosha gene specifically in T reg cells. Mice with IRES-Cre knocked into the X-linked Foxp3 gene were used for T reg cell-specific deletion (31). Both female mice homozygous for and male mice hemizygous for the Cre insertion were examined, and alleles for both are designated as Foxp3Cre/Cre(Y). Both DroshaF/Delta Foxp3Cre/Cre(Y) and DicerF/F Foxp3Cre/Cre(Y) mice became sick at 2-3 wk of age, with a 100% mortality rate (Fig. 6 A). Sick DroshaF/Delta Foxp3Cre/Cre(Y) mice displayed massive lymphadenopathy and, to a lesser extent, splenomegaly (Fig. 6, B and C). In moribund mice, all leukocyte populations appeared to have expanded equally, except for a consistent increase in the frequency of CD8+ T cells (Fig. 6 D). Increases in the frequencies of CD62Llo44hi CD4+ and CD8+ T cells were observed, suggesting aberrant activation (Fig. 6 E). Hyper-IFN-gamma secretion by both CD4+ and CD8+ T cells, and hyper-IL-4 secretion by CD4+ T cells were also observed in these mice (Fig. 6, F and G). Large areas of the liver and lung were infiltrated by inflammatory cells in moribund DroshaF/Delta Foxp3Cre/Cre(Y) mice (Fig. 6 J; and Table S2, available at ). Cuffing around blood vessels was also observed in other tissues, including the pancreas, kidney, and skeletal muscle. This phenotype is identical to mice lacking Foxp3 or Foxp3-expressing cells (2, 3). This phenotype was also recapitulated in DicerF/F Foxp3Cre/Cre(Y) mice (unpublished data).
###end p 37
###begin p 38
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scurfy</italic>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T reg cell&#8211;specific Drosha or Dicer deficiency recapitulates the <italic>scurfy</italic> phenotype.</bold>
###xml 123 130 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 136 146 132 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 117 146 117 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 153 156 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 162 172 158 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 148 172 144 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 198 201 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 207 217 203 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 192 217 188 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 225 232 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 238 243 230 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/+</sup>
###xml 219 243 215 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/+</sup></italic>
###xml 251 254 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 260 265 252 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/+</sup>
###xml 245 265 237 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/+</sup> Foxp3<sup>Cre/+</sup></italic>
###xml 272 275 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 281 291 273 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 267 291 259 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/+</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 302 305 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/+</sup>
###xml 311 316 303 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/+</sup>
###xml 297 316 289 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/+</sup> Foxp3<sup>Cre/+</sup></italic>
###xml 365 372 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 378 385 366 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre</sup>
###xml 359 385 351 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre</sup></italic>
###xml 484 491 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 497 504 481 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre</sup>
###xml 478 504 466 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre</sup></italic>
###xml 514 521 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 527 532 507 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Y</sup>
###xml 508 532 492 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Y</sup></italic>
###xml 682 683 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 712 713 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 730 731 692 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 754 755 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 796 803 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 809 816 764 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre</sup>
###xml 790 816 749 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre</sup></italic>
###xml 902 909 857 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 915 922 866 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre</sup>
###xml 896 922 851 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre</sup></italic>
###xml 965 966 916 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 978 979 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1003 1010 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1016 1023 963 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre</sup>
###xml 997 1023 948 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre</sup></italic>
###xml 1089 1090 1036 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1235 1245 1182 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 1230 1245 1177 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 386 391 <span type="species:ncbi:10090">mouse</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
T reg cell-specific Drosha or Dicer deficiency recapitulates the scurfy phenotype. (A) Kaplan-Meyer survival plot of DroshaF/Delta Foxp3Cre/Cre(Y), DicerF/F Foxp3Cre/Cre(Y), and control mice (DroshaF/+ Foxp3Cre/Cre(Y), DroshaF/Delta Foxp3Cre/+, DroshaF/+ Foxp3Cre/+, DicerF/+ Foxp3Cre/Cre(Y), and DicerF/+ Foxp3Cre/+). (B) Massive lymphadenopathy in a female DroshaF/Delta Foxp3Cre/Cre mouse. Shown are the cervical lymph nodes. (C) Cell counts of lymphoid organs from moribund DroshaF/Delta Foxp3Cre/Cre or DroshaF/Delta Foxp3Cre/Y mice and littermate controls. Data represent the mean +/- SD of four mice at 2.5-3 wk of age. (D) Only marginal changes in the proportions of B (CD19+), gammadeltaT (TCRgammadelta+), myeloid (CD11b+), and T cells (TCRbeta+) in the spleen and lymph nodes of DroshaF/Delta Foxp3Cre/Cre mice. (E) Aberrant T cell activation in the spleen and lymph nodes of moribund DroshaF/Delta Foxp3Cre/Cre mice. (F and G) Cytokine expression by CD8+ (F) and CD4+ (G) T cells from DroshaF/Delta Foxp3Cre/Cre mice. (H and I) Foxp3 expression in total splenocytes (H) and CD4+ T cells (I). Percentages of cells are shown in D-I. (J) H&E-stained sections of the lung (i and iii) and liver (ii and iv). Designation of Foxp3Cre/Cre(Y) alleles indicates that both males and females were included in the experiments. Bars, 100 mum.
###end p 38
###begin p 39
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 173 188 173 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, H and I</xref>
###xml 268 275 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 262 283 262 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 324 325 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 329 331 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 353 354 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 358 360 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
This early lymphoproliferative phenotype was not caused by a loss of T reg cells but rather by loss of function, because Foxp3+ cells could still be detected in these mice (Fig. 6, H and I). In fact, the T reg cell phenotype in these mice was similar to that in DroshaF/Delta CD4-cre mice. There was a reduction of the Foxp3+CD25lo population, but Foxp3+CD25hi cells were present.
###end p 39
###begin p 40
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 603 610 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 616 626 612 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 597 626 597 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 655 662 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 668 673 660 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/+</sup>
###xml 649 673 645 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/+</sup></italic>
###xml 724 725 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 985 992 977 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 998 1003 986 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/+</sup>
###xml 979 1003 971 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/+</sup></italic>
###xml 1133 1134 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1170 1177 1158 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1164 1185 1152 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1195 1202 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1208 1218 1188 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 1189 1218 1173 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
###xml 1419 1423 <span type="species:ncbi:10090">mice</span>
It has previously been suggested that Foxp3+ T reg cells express a high frequency of high-affinity self-reactive TCRs (32). This hypothesis remains controversial, as a more recent analysis found that TCRs derived from T reg and non-T reg cells recognize foreign peptide-MHC complex with similar frequencies (33). Nevertheless, if a subset of Foxp3+ cells does express self-reactive TCRs, Drosha deficiency potentially may not only abrogate suppressive activity but also allow for activation through such TCRs. Thus, a Foxp3+ population itself may be responsible for this inflammatory phenotype in DroshaF/Delta Foxp3Cre/Cre(Y) mice. However, female DroshaF/Delta Foxp3Cre/+ heterozygous mice, in which only half of the Foxp3+ cells express cre because of random X chromosome inactivation, do not develop inflammatory disease and remain healthy. This suggests that the loss of Drosha-dependent regulatory pathways simply abrogates the function of T reg cells, and in heterozygous DroshaF/Delta Foxp3Cre/+ mice, the remaining 50% of T reg cells that express Drosha are sufficient to prevent this early onset disease. Furthermore, Foxp3+ T cells from either moribund DroshaF/Delta CD4-cre or DroshaF/Delta Foxp3Cre/Cre(Y) mice did not coexpress IFN-gamma or IL-17 (Fig. S8, available at ). The finding that both T reg cell-specific Drosha- and Dicer-deficient mice display a phenotype identical to that of Foxp3-deficient mice demonstrates an absolute requirement for miRNA pathways in the function of T reg cells.
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer</italic>
###xml 139 140 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 391 393 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 395 397 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 460 462 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 807 809 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 811 813 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
In this study, we have shown identical phenotypes when either the Drosha or Dicer gene was inactivated in TCRalphabeta T cells and in Foxp3+ T reg cells. These results confirm that these two RNaseIII enzymes function in the same biological pathway in miRNA biogenesis. However, it has previously been shown that Dicer also functions in the biogenesis of other siRNAs, in addition to miRNAs (22, 23), and Drosha was suggested to have a role in rRNA maturation (24). Our results indicate that there is no defect in rRNA production in the absence of Drosha, and they are consistent with loss of miRNAs as the primary cause underlying the phenotypes observed. Although it is quite possible that Dicer-deficient cells will also exhibit other more subtle phenotypes, such as the derepression of retrotransposons (22, 23), it appears that it is miRNAs, rather than other Dicer-dependent small RNAs, that are critical for most cells.
###end p 42
###begin p 43
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer</italic>
###xml 276 278 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 323 325 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 806 807 803 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 842 849 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 855 865 848 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 836 865 833 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 875 878 868 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 884 894 877 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 870 894 863 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 1016 1017 1009 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1040 1045 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 1066 1073 1059 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1060 1081 1053 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1471 1473 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 1778 1780 1767 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
Ablation of the miRNA biogenesis pathway late in thymocyte differentiation, either by deleting Drosha or Dicer, did not prevent the development or maintenance of a peripheral mature T cell pool. Similarly, deletion of Dicer in terminally differentiated pancreatic beta cells (20) or in dopaminoceptive postmitotic neurons (34) did not result in the loss of these cells. Instead, functional defects were manifest in these cells. In the case of the T cell compartment, a functional defect was particularly prominent in the T reg lineage. Either Drosha or Dicer deficiency led to defective Foxp3 induction and suppressive activity in these cells. Loss of miRNA biogenesis in T reg cells had a devastating effect on the survival of mice when the rest of the immune system was miRNA competent. Even though Foxp3+ cells were still present in DroshaF/Delta Foxp3Cre/Cre(Y) and DicerF/F Foxp3Cre/Cre(Y) mice, the animals succumbed to autoimmune lymphoproliferative disease indistinguishable from that in mice that lack Foxp3+ cells or a functional Foxp3 gene. Even in DroshaF/Delta CD4-cre mice, in which all T cells lacked the ability to generate mature miRNAs, spontaneous lethal inflammatory disease still ensued, albeit much later in life. This indicates that miRNAs are indispensable for the function of T reg cells. This is unlike what has been described for some cell types, such as postmitotic Purkinje neurons, in which the loss of Dicer activity results in cell death (35). Why the loss of miRNA-dependent regulation in some cell types results in cell death instead of functional perturbations is unclear. It may be that neurodegeneration is secondary to the loss of function. Alternatively, components of the apoptotic machinery may be subject to miRNA-dependent regulation (21).
###end p 43
###begin p 44
###xml 369 371 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 741 743 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 927 928 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1219 1221 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1337 1339 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 1750 1751 1747 1748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1782 1784 1779 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
How might miRNAs enable a T reg cell to be immunosuppressive? T reg cells have been postulated to act via a myriad of mechanisms. These include secretion of immunomodulatory cytokines, such as TGF-beta and IL-10, modulation of co-stimulatory molecules on antigen-presenting cells, cytotoxic T lymphocyte antigen 4-induced tryptophan catabolism and direct cytotoxicity (36). Both in vitro and in vivo studies have provided compelling evidence that all of these and other mechanisms contribute to T reg cell-mediated immunosuppresion. However, abrogation of any one mechanism does not significantly impair the function of these cells. Even the ablation of IL-10 production by T reg cells results in only mild inflammation at mucosal surfaces (31). It is likely that T reg cells use multiple mechanisms to maintain immune homeostasis. Ablation of miRNA biogenesis is the first example that completely phenocopies the loss of Foxp3+ cells. This suggests that miRNAs may concurrently modulate multiple pathways in T reg cells, and the loss of this modulation may in effect abrogate multiple immunosuppressive mechanisms used by these cells. In addition to conferring some of the immunosuppressive properties of T reg cells (37), Foxp3 itself has been shown to be responsible for a significant component of the miRNA signature in these cells (28). Because miRNA pathways are also required for inducing and maintaining Foxp3 expression, this suggests that there is a positive feedback loop between Foxp3 and miRNAs that is critical for the function of T reg cells. Interestingly, like many other markers of T reg cells such as CD25, cytotoxic T lymphocyte antigen 4, and glucocorticoid-induced TNFR, a T reg cell miRNA signature is also induced in naive CD4+ T cells after TCR activation (28).
###end p 44
###begin p 45
###xml 112 119 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 125 135 121 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 106 135 106 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 146 153 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 140 161 136 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 333 340 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 346 356 334 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 327 356 319 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 367 374 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 361 382 349 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 601 608 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 595 616 579 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 764 771 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 777 787 753 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 758 787 738 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 1113 1127 1089 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha CD4-cre</italic>
###xml 1167 1168 1143 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1176 1177 1152 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
Although spontaneous inflammatory disease appeared to be related to a loss of T reg cell function in both DroshaF/Delta Foxp3Cre/Cre(Y) and DroshaF/Delta CD4-cre mice, only in the former was there massive lymphoproliferative disease, whereas lymphopenia occurred in the latter. The striking difference between the lifespans of DroshaF/Delta Foxp3Cre/Cre(Y) and DroshaF/Delta CD4-cre mice suggests that different mechanisms may be involved in the two diseases. It is clear that Drosha-dependent pathways are required for T reg cell function. However, the finding that the conventional T cells in DroshaF/Delta CD4-cre mice did not proliferate inappropriately to cause lymphadenopathy and early onset disease like the Drosha-sufficient conventional T cells in DroshaF/Delta Foxp3Cre/Cre(Y) mice suggests that Drosha-deficient T cells are also defective in some way, even though they are able to polarize into inflammatory effector cells both in vitro and in vivo. One possible defect may be the proliferative potential of Drosha-deficient T cells, as suggested by the lymphopenia rather than lymphoproliferation in Drosha CD4-cre mice. Indeed, both Drosha-deficient CD4+ and CD8+ T cells displayed reduced proliferation in vitro in response to anti-CD3 stimulation, but this was overcome when anti-CD28 co-stimulation was provided (Fig. S9 A, available at ). Furthermore, these cells also proliferated marginally slower than wild-type cells when adoptively cotransferred into the same lymphopenic Rag-deficient hosts (Fig. S9 B).
###end p 45
###begin p 46
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 355 362 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 368 378 364 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 349 378 349 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 388 391 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 397 407 393 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 383 407 379 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 519 524 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 541 542 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 549 550 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 551 552 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 581 588 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 575 596 571 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 636 637 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 832 839 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 845 855 825 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 826 855 810 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 862 865 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 871 881 851 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 857 881 837 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
miRNAs may be involved in regulating TCR signaling and/or proliferation in conventional T cells. One miRNA, miR-181a, has previously been shown to modulate TCR sensitivity (38). Increasing the levels of miR-181a in T cells was found to lower the threshold of signaling. Thus, loss of miR-181a may render T cells less sensitive to TCR engagement. In DroshaF/Delta Foxp3Cre/Cre(Y) and DicerF/F Foxp3Cre/Cre(Y) mice, there was a dramatic expansion of all leukocytes, as has been previously shown in mice with mutations in Foxp3 or lacking Foxp3+ cells 2-4. However, in moribund DroshaF/Delta CD4-cre mice, there were only increases in Gr-1+ and gammadeltaT cells without lymphoproliferation, despite only T cells being defective for miRNA biogenesis. This suggests that the generalized lymphoproliferation and lymphadenopathy in DroshaF/Delta Foxp3Cre/Cre(Y), DicerF/F Foxp3Cre/Cre(Y), or Foxp3-deficient mice is entirely secondary to the activation of T cells.
###end p 46
###begin p 47
###xml 50 51 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 63 64 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 92 93 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 120 127 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 114 135 110 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 209 216 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 222 232 206 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 203 232 191 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 268 269 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 285 292 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 279 300 263 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 481 488 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 494 504 466 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 475 504 451 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
Another difference was the appearance of IFN-gamma+- and IL-17A+- but not IL-4-producing CD4+ T cells in moribund DroshaF/Delta CD4-cre mice, whereas IFN-gamma- and IL-4-producing cells were dominant in DroshaF/Delta Foxp3Cre/Cre(Y) mice. The differentiation of IL-17A+ cells in DroshaF/Delta CD4-cre mice may be related to the inability of Drosha-deficient conventional T cells to rapidly proliferate and up-regulate IFN-gamma and IL-4 in the perinatal period, as occurs in DroshaF/Delta Foxp3Cre/Cre(Y) mice. The massive expansion of Th1 and Th2 cells in the latter case may inhibit the differentiation of Th17 cells.
###end p 47
###begin p 48
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 289 295 <span type="species:ncbi:9606">humans</span>
###xml 364 370 <span type="species:ncbi:9606">humans</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 502 507 <span type="species:ncbi:9606">human</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1153 1158 <span type="species:ncbi:9606">human</span>
This study has clearly demonstrated a critical requirement for miRNA-dependent regulation in the prevention of spontaneous inflammation/autoimmunity. Might polymorphisms or mutations in miRNA machinery components or specific miRNA genes contribute to inflammatory or autoimmune disease in humans? Although mutations in this pathway have not yet been identified in humans with autoimmune disease, it has been shown that miR-17-92 overexpression in mice leads to spontaneous autoimmunity (39). A link to human disease, however, has been made for Drosha. Expression of Drosha, but not Dicer or DGCR8, is up-regulated in cervical squamous cell carcinomas and esophageal tumors (40, 41). Furthermore, the oncogenic ALL-1 fusion proteins have been shown to recruit Drosha to specific miRNA loci in leukemic cells lines (42), which may underlie the overexpression of certain miRNAs in leukemia. There is now a significant body of evidence correlating mutations or misexpression of miRNAs with numerous human cancers (43). Thus, continued efforts to gain a better understanding of miRNA biogenesis and function will undoubtedly provide significant insight into human disease.
###end p 48
###begin title 49
MATERIALS AND METHODS
###end title 49
###begin title 50
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 50
###begin p 51
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">exon9</italic>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
A targeting construct containing exon 9 of Drosha flanked by LoxP sites and a LopP-flanked neomycin selection cassette (Neo) was assembled from genomic fragments subcloned from the bacterial artificial chromosome clone RP23-354M9. A LoxP-exon9-LoxP-Neo-LoxP configuration was used such that cre-mediated recombination between the 5' and middle LoxP sites would yield a conditional allele, whereas recombination between the 5' and 3' LoxP sites would yield a null allele. EcoRI and SacI sites were inserted at the 5' and 3' LoxP sites, respectively, to allow for screening by Southern blotting. The construct was targeted into E14 129Sv-derived embryonic stem cells, from which mice were derived. These were bred with EIIA-cre mice, which transiently express cre in the early embryo, to obtain progeny harboring either the conditional or the null allele, and were then backcrossed onto the C57BL/6 genetic background for four more generations.
###end p 51
###begin p 52
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dicer<sup>F/F</sup></italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4-cre</italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre</sup>
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3<sup>Cre</sup></italic>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 169 177 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EIIA-cre</italic>
###xml 185 190 185 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">CreER</sup>
###xml 179 190 179 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26<sup>CreER</sup></italic>
###xml 196 202 196 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd45.1</italic>
###xml 273 276 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2<sup>&#8722;/&#8722;</sup></italic>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
DicerF/F (provided by M. McManus, University of California, San Francisco, San Francisco, CA) (44), CD4-cre (25), and Foxp3Cre (31) mice have previously been described. EIIA-cre, Rosa26CreER, and Cd45.1 mice were purchased from Jackson ImmunoResearch Laboratories, and Rag2-/- mice were purchased from Taconic. The mice were housed in specific pathogen-free conditions at the animal facility of the Skirball Institute. All animal experiments were performed in accordance with approved protocols for the New York University Institutional Animal Care and Usage Committee.
###end p 52
###begin title 53
Organ preparation and cell purifications.
###end title 53
###begin p 54
Lymphocytes were prepared from thymi, spleens, and lymph nodes by grinding the organs through a 100-mum mesh. Red blood cells were removed from splenic cell suspensions by lysis with ACK buffer (BioWhittaker). Lymphoid populations were enriched by MACS magnetic bead purification (Miltenyi Biotec) and sorted to high purity on a FACSAria (BD Biosciences). Organs for histological analyses were fixed in 10% buffered formalin, dehydrated, and paraffin embedded before sectioning and staining with hematoxylin and eosin (H&E).
###end p 54
###begin title 55
Southern and Northern blotting.
###end title 55
###begin p 56
Genomic DNA was prepared from cells by standard techniques and digested overnight with restriction enzymes. DNA fragments were resolved on a 0.7% agarose gel before transfer onto a membrane (Hybond-XL; GE Healthcare), and were probed with radiolabeled DNA probes.
###end p 56
###begin p 57
###xml 32 35 32 35 <sc xmlns:xlink="http://www.w3.org/1999/xlink">zol</sc>
###xml 429 431 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
Total RNA was purified using TRIzol (Invitrogen) according to the manufacturer's protocol, with one modification: RNAs were precipitated from the aqueous phase using 2x volumes of ethanol at -80degreesC for 1 h before centrifugation. Detection of small RNA species was performed by resolving 10 mug of total RNA on a 15% polyacrylamide gel and Northern blotting with radiolabeled oligonucleotide probes, as previously described (45). For the detection of long RNA species, 20 mug of total RNA was resolved on a 1% formaldehyde agarose gel before Northern blotting with a radiolabeled oligonucleotide probe. Northern blotting was performed with the following probes: 5'-TAACCGATTTCAGATGGTGCTA-3' (miR-29a), 5'-AGTAGTGCTTTCTACTTTATG-3' (miR-142-5p), 5'-TCCATAAAGTAGGAAACACTACA-3' (miR-142-3p), and 5'-CACTGGTACAAGGGTTGGGAGA-3' (miR-150).
###end p 57
###begin title 58
RT-PCRs.
###end title 58
###begin p 59
First-strand RT was performed on total RNA using Superscript II (Invitrogen). The following forward primers were used to detect specific exon boundaries in the Drosha cDNA: 5'-GGCTGGGCTTTGATGGCGGCGACCCCGGGA-3' (exon 1 forward), 5'-AACCTACATCGTGAGCGGAAGATGTAGCCT-3' (exon 3 forward), 5'-GACCCCAAAACCTGCGACTTCTTCATC-3' (exon 4), 5'-GCAGATCACCGTCTCTAGAAA-3' (exon 5), 5'-GCACACCAGAGTTGCCTGGGGAGATGATTA-3' (exon 6), and 5'-AAGCAGGCTCCGTGATTTGTATGAC-3' (exon 8), with the reverse primer 5'-CTCTTCTCCGGGATAAATGCTGTGG-3' (exon 10).
###end p 59
###begin p 60
The following primer pairs were used to detect Drosha exon boundaries by quantitative PCR: 5'-TGCAAGGCAATACGTGTCAT-3' and 5'-GGCCTGAGAGTTCGAGTAGG for exon 3/4; and 5'-GACGACGACAGCACCTGTT-3' and 5'-GATAAATGCTGTGGCGGATT-3' for exon 9/10. 5'-CACAGCTTCTTTGCAGCTCCTT-3' and 5'-CGTCATCCATGGCGAACTG-3' were used to amplify beta-actin as a control.
###end p 60
###begin title 61
Western blotting.
###end title 61
###begin p 62
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 245 251 <span type="species:ncbi:9986">rabbit</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
Cells were lysed in 50 mM Tris (pH 8), 150 mM NaCl, 1% NP-40, and protease inhibitors, and the insoluble components were removed by centrifugation. The equivalent of 2 x 106 cells was resolved on a 7% polyacrylamide gel and immunoblotted with a rabbit polyclonal antibody against the N terminus of Drosha (Millipore) or a mouse monoclonal antibody against beta-tubulin (Invitrogen).
###end p 62
###begin title 63
FACS analyses.
###end title 63
###begin p 64
Analyses were performed on an LSRII (BD Biosciences). All antibodies were purchased from eBioscience or BD Biosciences. For the detection of intracellular cytokine expression, total cells were restimulated in vitro with 50 ng/ml PMA and 1 muM ionomycin for 3 h in the presence of GolgiStop (BD Biosciences). After staining for cell surface markers, the cells were fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences) and stained for cytokine expression. Detection of intranuclear Foxp3 expression was performed by fixation and permeabilization with Foxp3 fixation/permeabilization buffer (eBioscience) before staining for Foxp3.
###end p 64
###begin title 65
In vitro T cell culture.
###end title 65
###begin p 66
###xml 248 249 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
FACS-purified T cells were activated in vitro with 5 mug/ml of plate-bound anti-CD3 and 1 mug/ml of soluble anti-CD28 antibodies in RPMI supplemented with 10% FCS, 5 mM beta-mercaptoethanol, and antibiotics. Cells were plated at a density of 5 x 105/ml at day 0 of culture. Various cytokines and neutralizing antibodies were added at day 0 or 1 of culture. All cytokines and antibodies were purchased from PeproTech or eBioscience.
###end p 66
###begin p 67
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd45.1</italic>
###xml 191 192 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 195 196 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 366 367 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 371 372 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 396 397 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 407 408 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 427 428 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 529 535 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd45.1</italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
For in vitro suppression assays, naive (CD62Lhi44lo25-) CD4+ T cells (effectors) were FACS purified from Cd45.1 mice and loaded with 5 muM CFSE (Invitrogen), and mixed with FACS-purified CD25+CD4+ T reg cells at various ratios. Total splenocytes from C57BL/6 mice inactivated with 50 mug/ml mitomycin C (Sigma-Aldrich) for 45 min were used as APCs. A total of 4 x 105 CD4+ cells (CFSE-loaded CD25- plus CD25+) was mixed with 105 APCs plus 1 mug/ml anti-CD3 antibody per well of a 96-well round-bottom plate. Proliferation of the Cd45.1 effector cells was analyzed by CFSE dilution.
###end p 67
###begin title 68
T cell transfers.
###end title 68
###begin p 69
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag2<sup>&#8722;/&#8722;</sup></italic>
CD45.1 and CD45.2 congenically marked cells were mixed at a 1:1 ratio and loaded with CFSE. The cells were resuspended in PBS at 108 cells/ml, and a total of 107 cells were transferred into Rag2-/- recipients by injection into the retroorbital plexus.
###end p 69
###begin title 70
Online supplemental material.
###end title 70
###begin p 71
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha</italic>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 257 264 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 251 272 251 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 310 317 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 304 325 300 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 587 588 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 715 716 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 818 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 805 826 782 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 836 843 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 849 859 818 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 830 859 803 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 1048 1055 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1042 1063 1011 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> CD4-cre</italic>
###xml 1122 1129 1087 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/&#916;</sup>
###xml 1135 1145 1096 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cre/Cre(Y)</sup>
###xml 1116 1145 1081 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosha<sup>F/&#916;</sup> Foxp3<sup>Cre/Cre(Y)</sup></italic>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1146 1150 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows that multiple Drosha splice isoforms are expressed in mouse tissues. Fig. S2 depicts the generation of the conditional Drosha allele. Fig. S3 shows the accumulation of inflammatory cytokine-producing CD4+ T cells in the spleens of aging DroshaF/Delta CD4-cre mice. Fig. S4 depicts moribund DroshaF/Delta CD4-cre mice that do not develop splenomegaly or lymphadenopathy. Fig. S5 shows that defective TGF-beta-induced Foxp3 expression in the absence of Drosha is not due to thymocyte selection defects. Fig. S6 shows that enhanced IFN-gamma expression in Drosha-deficient CD4+ cells is not due to thymocyte selection defects. Fig. S7 depicts the induction of IFN-gamma expression in Drosha-deficient CD8+ cells. Fig. S8 shows that Foxp3 is not coexpressed with IFN-gamma or IL-17A in moribund DroshaF/Delta CD4-cre or DroshaF/Delta Foxp3Cre/Cre(Y) mice. Fig. S9 shows that Drosha-deficient T cells display a partial proliferation defect in response to TCR stimulation or lymphopenia. Table S1 provides a tissue survey of moribund DroshaF/Delta CD4-cre mice. Table S2 provides a tissue survey of moribund DroshaF/Delta Foxp3Cre/Cre(Y) mice. Online supplemental material is available at .
###end p 71
###begin p 72
###xml 69 73 <span type="species:ncbi:10090">mice</span>
We wish to thank Michael McManus for providing the Dicer conditional mice.
###end p 72
###begin p 73
M.M.W. Chong was a recipient of a postdoctoral fellowship from the Cancer Research Institute and is currently funded by a Helen L. and Martin S. Kimmel Center for Stem Cell Biology Postdoctoral Award. This work was supported by the Howard Hughes Medical Institute (D.R. Littman and A.Y. Rudensky).
###end p 73
###begin p 74
The authors have no conflicting financial interests.
###end p 74

